We are live on
!
Find out more
TEE
Tibra Equities Europe Portfolio holdings
AUM
$90.4M
1-Year Est. Return
37.81%
This Fund
S&P 500
This Quarter
Est. Return
-1.84%
1 Year Est. Return
+37.81%
3 Year Est. Return
+142.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65M
AUM Growth
-$259M
(-80%)
Cap. Flow
-$258M
Cap. Flow
% of AUM
-397.4%
Top 10 Holdings %
Top 10 Hldgs %
84.7%
Holding
272
New
32
Increased
2
Reduced
3
Closed
235
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$16.9M |
| 2 |
UFS
DOMTAR CORPORATION (New)
UFS
|
+$6.5M |
| 3 |
CVA
Covanta Holding Corporation
CVA
|
+$3.87M |
| 4 |
CLDR
Cloudera, Inc.
CLDR
|
+$1.74M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$37.6M |
| 2 |
Willis Towers Watson
WTW
|
+$35.7M |
| 3 |
KSU
Kansas City Southern
KSU
|
+$25.4M |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$22.6M |
| 5 |
TXNM
TXNM Energy Inc
TXNM
|
+$15.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 22.97% |
| 2 | Materials | 11.76% |
| 3 | Utilities | 6.05% |
| 4 | Technology | 4.78% |
| 5 | Financials | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
FVCBankcorp
FVCB
$331M
| – | – |
-18,000
| Closed | -$249K |
|
102
Gaia
GAIA
$48.1M
| – | – |
-29,900
| Closed | -$329K |
|
103
Galectin Therapeutics
GALT
$332M
| – | – |
-98,700
| Closed | -$316K |
|
104
Gencor Industries
GENC
$229M
| – | – |
-18,600
| Closed | -$226K |
|
105
Gold Fields
GFI
$35.9B
| – | – |
-41,700
| Closed | -$371K |
|
106
Graham Corp
GHM
$1.28B
| – | – |
-24,600
| Closed | -$338K |
|
|
CBIO
107
Crescent Biopharma
CBIO
$627M
| – | – |
-1,361
| Closed | -$316K |
|
108
Genie Energy
GNE
$382M
| – | – |
-48,400
| Closed | -$306K |
|
109
Genprex
GNPX
$2.25M
| – | – |
-2
| Closed | -$319K |
|
110
Genasys
GNSS
$79.2M
| – | – |
-59,800
| Closed | -$328K |
|
111
Goldgroup Mining Inc.
GORO
$180M
| – | – |
-133,900
| Closed | -$345K |
|
112
GSI Technology
GSIT
$256M
| – | – |
-50,000
| Closed | -$281K |
|
113
Gyre Therapeutics
GYRE
$758M
| – | – |
-10,560
| Closed | -$343K |
|
114
Huntington Bancshares
HBAN
$35.6B
| – | – |
-33,148
| Closed | -$473K |
|
115
Harrow
HROW
$1.51B
| – | – |
-32,400
| Closed | -$301K |
|
116
Intellicheck
IDN
$79.2M
| – | – |
-40,700
| Closed | -$341K |
|
117
Information Services Group
III
$259M
| – | – |
-61,500
| Closed | -$360K |
|
118
Immersion
IMMR
$254M
| – | – |
-32,300
| Closed | -$283K |
|
119
Imperial Oil
IMO
$62.2B
| – | – |
-10,770
| Closed | -$328K |
|
120
InfuSystem Holdings
INFU
$245M
| – | – |
-25,510
| Closed | -$530K |
|
121
Iron Mountain
IRM
$36.2B
| – | – |
-24,574
| Closed | -$1.04M |
|
122
Investar Holding Corp
ISTR
$415M
| – | – |
-15,200
| Closed | -$348K |
|
123
Invesco
IVZ
$14.2B
| – | – |
-34,707
| Closed | -$928K |
|
124
IZEA Worldwide
IZEA
$60.8M
| – | – |
-21,575
| Closed | -$220K |
|
125
Kinross Gold
KGC
$32B
| – | – |
-37,142
| Closed | -$235K |
|
Similar funds
EM
BBHBI
EA
SCMU
DCM
BCIMC
LSC
RCM
Tibra Equities Europe's Q3 2021 Portfolio in Review
As of Q3 2021, Tibra Equities Europe held 272 positions worth $65M, down 80% from $324M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Tibra Equities Europe withdrew a net $258M in Q3 2021, closing 235 positions and reducing 3 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $37.6M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 23% of assets, up from 14% a quarter earlier, followed by Materials and Utilities.
Against the trend, Tibra Equities Europe opened a new position in DOMTAR CORPORATION (New) worth $6.46M.
- Tibra Equities Europe's largest Q3 2021 buy was DOMTAR CORPORATION (New): 118,493 shares worth $6.46M.
- Tibra Equities Europe added most to iShares Russell 2000 ETF in Q3 2021, an estimated $16.9M increase.
- Tibra Equities Europe's biggest Q3 2021 reduction was IHS Markit Ltd. Common Shares, cutting an estimated $22.6M.
- Tibra Equities Europe fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $37.6M.
- Tibra Equities Europe's ten largest holdings make up 85% of its $65M portfolio in Q3 2021.
- Tibra Equities Europe opened 32 new positions and closed 235 in Q3 2021.
- Tibra Equities Europe's portfolio value fell 80% quarter-over-quarter to $65M.
Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.